Novo Nordisk Lilly Shares Slump on Price-Cut Loom Plans
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Mistakes happen, but you can recover. This starter guide shows how to assess the damage, prioritize essential expenses, and rebuild your budget step by step.
20,620 articlesNews of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
A new global liveability ranking places a major city at the bottom in 2026, triggering concerns about investment, hou...
AI infrastructure has reshaped markets, but not every stock fits every investor. This guide explains what CoreWeave d...
A federal judge denied the FTC’s request for a partial summary judgment in the Zillow-Redfin rental listings antitrus...
A Singapore-based crypto miner reveals it has sold all mined Bitcoin to shore up liquidity for AI and high-performanc...
A Florida fraud case highlights how life insurance applications used stolen personal information for advance commissi...
A practical guide to understanding First Solar's 2025 earnings journey. Learn what drives profits, how to read the gu...
As mid-2026 trading picks up, McDonald’s demonstrates stronger growth and cash flow versus Pfizer, which relies on in...
NVIDIA is expected to report a $65.7 billion Q4 revenue figure as investors weigh margin recovery against AI-driven d...
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Snowflake’s Q4 FY26 results hinge on one key metric—RPO—to gauge AI-driven demand and the strength of its data platfo...
Remitly Global surged in early 2026 as it grabbed remittance market share and turned the corner on profitability. Thi...